Blueprint Medicines Corp. - Wutah bathi EPS kuartalan BPMC

Logo korporat perusahaan Blueprint Medicines Corp. (BPMC)

Stable demand for innovative medicine makes Blueprint Medicines (BPMC) a defensive asset independent of macroeconomic factors. Quarterly EPS variation confirms this resilience, with the metric holding around -99.40. Revenue growth from Ayvakit and new indications for mastocytosis are driving the momentum. The strategy is based on developing precision kinase inhibitors for the therapy of rare genetic mutations.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan blueprintmedicines.com (BPMC): kanggo periode 04.07.2022 - 02.08.2025

Rincian analitis perusahaan Blueprint Medicines

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Blueprint Medicines Corp. - BPMC
Barang unggulan Blueprint Medicines Corporation

This indicator measures the quarterly growth rate of net earnings per share, serving as a filter to exclude fundamentally weak issuers and assess alpha potential. By analyzing the quarterly EPS trend, an investor can determine how effectively Blueprint Medicines (BPMC) converts investments in leading oncologists and R&D resources into actual financial results, which is critical for minimizing portfolio drawdown risks.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CGEM (cullinanoncology.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immuneering Inc. IMRX|Wutah bathi EPS kuartalan CCCC|Black Diamond Therapeutics - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Repare Therapeutics Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan PMVP|KPTI: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|propanc.com - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|BGMS: Wutah bathi EPS kuartalan|Aadi Bioscience Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|ALRN (Aileron Therapeutics Inc) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)